Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent

Yasuhiro Kawai, Kosuke Masutani, Kumiko Torisu, Ritsuko Katafuchi, Shigeru Tanaka, Akihiro Tsuchimoto, Koji Mitsuiki, Kazuhiko Tsuruya, Takanari Kitazono

研究成果: ジャーナルへの寄稿記事

3 引用 (Scopus)

抄録

Serum albumin is the major intravascular antioxidant. Though oxidative stress plays an important role in the pathophysiology of Immunoglobulin A nephropathy (IgAN), the association between serum albumin and the progression of IgAN is not entirely understood. This retrospective cohort study of 1,352 participants with biopsy-proven IgAN determined the associations between serum albumin level and the incidence of end-stage renal disease (ESRD) using a Cox proportional hazards model. Patients were divided into three groups by tertiles of serum albumin level: Low, Middle, and High group (3.9 g/dL, 4.0–4.3 g/dL, 4.4 g/dL, respectively). During the median 5.1-year follow-up period, 152 patients (11.2%) developed ESRD. Participants in the Low group had a 1.88-fold increased risk for ESRD compared with those in the High group after adjustment for clinical parameters, including urinary protein excretion, and pathological parameters (Oxford classification). We also experimentally proved the antioxidant capacity of albumin on mesangial cells. The intracellular reactive oxygen species and mitochondrial injury, induced by hydrogen peroxide were significantly attenuated in albumin-pretreated mouse mesangial cells and human kidney cells compared with γ-globulin-pretreated cells. Low serum albumin level is an independent risk factor for ESRD in patients with IgAN. The mechanism could be explained by the antioxidant capacity of serum albumin.

元の言語英語
記事番号e0196655
ジャーナルPloS one
13
発行部数5
DOI
出版物ステータス出版済み - 5 2018

Fingerprint

IGA Glomerulonephritis
immunoglobulin A
serum albumin
kidney diseases
Serum Albumin
Immunoglobulin A
Chronic Kidney Failure
albumins
Albumins
Antioxidants
antioxidants
incidence
Incidence
Mesangial Cells
Oxidative stress
Biopsy
Globulins
Proportional Hazards Models
Hydrogen Peroxide
Reactive Oxygen Species

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

これを引用

Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy : A possible role of albumin as an antioxidant agent. / Kawai, Yasuhiro; Masutani, Kosuke; Torisu, Kumiko; Katafuchi, Ritsuko; Tanaka, Shigeru; Tsuchimoto, Akihiro; Mitsuiki, Koji; Tsuruya, Kazuhiko; Kitazono, Takanari.

:: PloS one, 巻 13, 番号 5, e0196655, 05.2018.

研究成果: ジャーナルへの寄稿記事

@article{71ed9cfb2a2345e18e404f8a8b74a87f,
title = "Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy: A possible role of albumin as an antioxidant agent",
abstract = "Serum albumin is the major intravascular antioxidant. Though oxidative stress plays an important role in the pathophysiology of Immunoglobulin A nephropathy (IgAN), the association between serum albumin and the progression of IgAN is not entirely understood. This retrospective cohort study of 1,352 participants with biopsy-proven IgAN determined the associations between serum albumin level and the incidence of end-stage renal disease (ESRD) using a Cox proportional hazards model. Patients were divided into three groups by tertiles of serum albumin level: Low, Middle, and High group (3.9 g/dL, 4.0–4.3 g/dL, 4.4 g/dL, respectively). During the median 5.1-year follow-up period, 152 patients (11.2{\%}) developed ESRD. Participants in the Low group had a 1.88-fold increased risk for ESRD compared with those in the High group after adjustment for clinical parameters, including urinary protein excretion, and pathological parameters (Oxford classification). We also experimentally proved the antioxidant capacity of albumin on mesangial cells. The intracellular reactive oxygen species and mitochondrial injury, induced by hydrogen peroxide were significantly attenuated in albumin-pretreated mouse mesangial cells and human kidney cells compared with γ-globulin-pretreated cells. Low serum albumin level is an independent risk factor for ESRD in patients with IgAN. The mechanism could be explained by the antioxidant capacity of serum albumin.",
author = "Yasuhiro Kawai and Kosuke Masutani and Kumiko Torisu and Ritsuko Katafuchi and Shigeru Tanaka and Akihiro Tsuchimoto and Koji Mitsuiki and Kazuhiko Tsuruya and Takanari Kitazono",
year = "2018",
month = "5",
doi = "10.1371/journal.pone.0196655",
language = "English",
volume = "13",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Association between serum albumin level and incidence of end-stage renal disease in patients with Immunoglobulin A nephropathy

T2 - A possible role of albumin as an antioxidant agent

AU - Kawai, Yasuhiro

AU - Masutani, Kosuke

AU - Torisu, Kumiko

AU - Katafuchi, Ritsuko

AU - Tanaka, Shigeru

AU - Tsuchimoto, Akihiro

AU - Mitsuiki, Koji

AU - Tsuruya, Kazuhiko

AU - Kitazono, Takanari

PY - 2018/5

Y1 - 2018/5

N2 - Serum albumin is the major intravascular antioxidant. Though oxidative stress plays an important role in the pathophysiology of Immunoglobulin A nephropathy (IgAN), the association between serum albumin and the progression of IgAN is not entirely understood. This retrospective cohort study of 1,352 participants with biopsy-proven IgAN determined the associations between serum albumin level and the incidence of end-stage renal disease (ESRD) using a Cox proportional hazards model. Patients were divided into three groups by tertiles of serum albumin level: Low, Middle, and High group (3.9 g/dL, 4.0–4.3 g/dL, 4.4 g/dL, respectively). During the median 5.1-year follow-up period, 152 patients (11.2%) developed ESRD. Participants in the Low group had a 1.88-fold increased risk for ESRD compared with those in the High group after adjustment for clinical parameters, including urinary protein excretion, and pathological parameters (Oxford classification). We also experimentally proved the antioxidant capacity of albumin on mesangial cells. The intracellular reactive oxygen species and mitochondrial injury, induced by hydrogen peroxide were significantly attenuated in albumin-pretreated mouse mesangial cells and human kidney cells compared with γ-globulin-pretreated cells. Low serum albumin level is an independent risk factor for ESRD in patients with IgAN. The mechanism could be explained by the antioxidant capacity of serum albumin.

AB - Serum albumin is the major intravascular antioxidant. Though oxidative stress plays an important role in the pathophysiology of Immunoglobulin A nephropathy (IgAN), the association between serum albumin and the progression of IgAN is not entirely understood. This retrospective cohort study of 1,352 participants with biopsy-proven IgAN determined the associations between serum albumin level and the incidence of end-stage renal disease (ESRD) using a Cox proportional hazards model. Patients were divided into three groups by tertiles of serum albumin level: Low, Middle, and High group (3.9 g/dL, 4.0–4.3 g/dL, 4.4 g/dL, respectively). During the median 5.1-year follow-up period, 152 patients (11.2%) developed ESRD. Participants in the Low group had a 1.88-fold increased risk for ESRD compared with those in the High group after adjustment for clinical parameters, including urinary protein excretion, and pathological parameters (Oxford classification). We also experimentally proved the antioxidant capacity of albumin on mesangial cells. The intracellular reactive oxygen species and mitochondrial injury, induced by hydrogen peroxide were significantly attenuated in albumin-pretreated mouse mesangial cells and human kidney cells compared with γ-globulin-pretreated cells. Low serum albumin level is an independent risk factor for ESRD in patients with IgAN. The mechanism could be explained by the antioxidant capacity of serum albumin.

UR - http://www.scopus.com/inward/record.url?scp=85047420425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047420425&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0196655

DO - 10.1371/journal.pone.0196655

M3 - Article

C2 - 29795559

AN - SCOPUS:85047420425

VL - 13

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e0196655

ER -